Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
10 participants
INTERVENTIONAL
2010-03-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Carnitine Supplementation on Liver and Muscle
NCT03439917
Migalastat Food Effect Study
NCT01489995
Effect of Pancreatic Polypeptide on Gastric Motor Function and Food Intake in Humans
NCT03854708
Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy
NCT01223742
Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease
NCT01016418
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Postprandial gastric emptying time will be measured for each subject, by 13C Breath Test.
Okara is a natural water extracted food grade soy product, contains approximately 35% protein (mfb), and about 43% of dietary fibers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nutrigal Okara - 100
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 20-65 years old
* Written Informed Consent
Exclusion Criteria
* On medication that may influence gastric emptying, or medication for weight loss
* Patient on PPI treatment, H2 Blockers or medication for weight loss
* Known allergies to soy
* Pregnancy or breast-feeding
* Smoking
* Athletes
* Metabolic syndrome or diabetes mellitus
* Family history of metabolic syndrome or diabetes mellitus
* Weight loss \> 2 kg during two months before the study
20 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nutrigal LTD
UNKNOWN
Tel-Aviv Sourasky Medical Center
OTHER_GOV
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tel Aviv Medical Center
Tel Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TASMC-10-NV-014-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.